Cargando…

Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals

Background: Conflicting data regarding the incidence of hepatocellular carcinoma (HCC) after cure of HCV infection with direct-acting antivirals (DAAs) remains. We investigated the incidence and risk factors to HCC after treatment with DAAs followed up for five years. Methods: A total of 1075 HCV pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leal, Cassia, Strogoff-de-Matos, Jorge, Theodoro, Carmem, Teixeira, Rosangela, Perez, Renata, Guaraná, Thais, de Tarso Pinto, Paulo, Guimarães, Tatiana, Artimos, Solange
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863874/ https://www.ncbi.nlm.nih.gov/pubmed/36680260 http://dx.doi.org/10.3390/v15010221

Ejemplares similares

Clinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients
por: Pereira, Renata Freire Alves, et al.
Publicado: (2014)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019)

Ankle-Brachial Index as a Predictor of Mortality in Hemodialysis: A 5-Year Cohort Study
por: Miguel, Jair Baptista, et al.
Publicado: (2017)

Metabolic acidosis in hemodialysis: a neglected problem in Brazil
por: Silva, Ana Paula Ramos, et al.
Publicado: (2020)

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
por: Huang, Chung-Feng, et al.
Publicado: (2019)

Molecular diversity of human parvovirus B19 during two outbreaks of erythema infectiosum in Brazil
por: Cubel Garcia, Rita de Cássia Nasser, et al.
Publicado: (2016)

Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed
por: Hassany, Sahar M, et al.
Publicado: (2020)

Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents
por: Mathur, Karan, et al.
Publicado: (2021)

Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
por: Lin, Wei-Chen, et al.
Publicado: (2020)

Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
por: Cabral, Loraine Kay D., et al.
Publicado: (2022)

Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
por: Tajiri, Kazuto, et al.
Publicado: (2022)

Differences in quality of life and cognition between the elderly and the very elderly hemodialysis patients
por: Viana, Fernanda Siqueira, et al.
Publicado: (2019)

Influence of vaccine-preventable diseases and HIV infection on demand for an infectious diseases service in Rio de Janeiro State, Brazil, over 22 years – Part II (1995-2016)
por: Ferreira, Laura da Cunha, et al.
Publicado: (2019)

Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals
por: Schietroma, Ivan, et al.
Publicado: (2018)

The use of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma
por: Economides, Minas, et al.
Publicado: (2017)

Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
por: Butt, Amna Subhan, et al.
Publicado: (2018)

Hepatocellular carcinoma after direct-acting antivirals: an unresolved problem. Review of five cases
por: Bartosiewicz, Agnieszka Joanna, et al.
Publicado: (2019)

Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues
por: Tampaki, Maria, et al.
Publicado: (2018)

Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
por: Kamp, William M., et al.
Publicado: (2019)

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
por: Tse, Chung Sang, et al.
Publicado: (2020)

Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
por: Fukumoto, Tsuyoshi, et al.
Publicado: (2022)

Albumin-to-protein ratio in spot urine samples for analysis of proteinuria selectivity in chronic kidney disease
por: Pereira, Miguel Augusto Martins, et al.
Publicado: (2022)

Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil
por: Holzmann, Iandra, et al.
Publicado: (2018)

Liver stiffness measurement predicts hepatocellular carcinoma development in patients treated with direct‐acting antivirals
por: Tachi, Yoshihiko, et al.
Publicado: (2017)

Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals
por: Syed, Taseen, et al.
Publicado: (2018)

Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
por: Dash, Srikanta, et al.
Publicado: (2020)

Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma
por: Teng, Wei, et al.
Publicado: (2019)

Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
por: Lee, Chang Hun, et al.
Publicado: (2021)

Spontaneous Rupture of Hepatocellular Carcinoma With Fatal Outcome in a Patient Taking Direct-Acting Antivirals
por: Dendane, Youness, et al.
Publicado: (2023)

Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
por: Fouad, Magdy, et al.
Publicado: (2021)

Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement
por: de Almeida, Renata Rocha, et al.
Publicado: (2017)

Association between extracellular volume control and survival in patients on short daily haemodialysis
por: Barra, Ana Beatriz Lesqueves, et al.
Publicado: (2020)

Evaluation of the Expression of CCR5 and CX3CR1 Receptors and Correlation with the Functionality of T Cells in Women infected with ZIKV during Pregnancy
por: Familiar-Macedo, Débora, et al.
Publicado: (2021)

The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?
por: Strazzulla, Alessio, et al.
Publicado: (2016)

Differential Longevity of Memory CD4 and CD8 T Cells in a Cohort of the Mothers With a History of ZIKV Infection and Their Children
por: Badolato-Corrêa, Jessica, et al.
Publicado: (2021)

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
por: Guarino, Maria, et al.
Publicado: (2018)

Hepatocellular carcinoma after direct-acting antiviral therapy for chronic HCV infection: Is it a real risk?
por: Dias, Cátia, et al.
Publicado: (2018)

Accelerated hepatocellular carcinoma recurrence rate after postoperative direct-acting antivirals treatment – preliminary report
por: Warzyszyńska, Karola, et al.
Publicado: (2017)

No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis
por: Rutledge, Stephanie M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b3oql4nbn3smnvd83l8dra53hf